Owens & Minor Inc. (OMI) SVP Charles C. Colpo Sells 7,500 Shares of Stock
Owens & Minor Inc. (NYSE:OMI) SVP Charles C. Colpo sold 7,500 shares of the business’s stock in a transaction that occurred on Monday, November 28th. The shares were sold at an average price of $34.33, for a total value of $257,475.00. Following the transaction, the senior vice president now owns 38,829 shares of the company’s stock, valued at approximately $1,332,999.57. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Shares of Owens & Minor Inc. (NYSE:OMI) opened at 34.29 on Wednesday. The stock has a market cap of $2.11 billion, a price-to-earnings ratio of 18.74 and a beta of 0.99. Owens & Minor Inc. has a 12-month low of $30.43 and a 12-month high of $41.48. The firm’s 50-day moving average price is $33.06 and its 200-day moving average price is $34.97.
Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Tuesday, November 1st. The company reported $0.51 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.51. The company earned $2.42 billion during the quarter, compared to the consensus estimate of $2.51 billion. Owens & Minor had a net margin of 1.16% and a return on equity of 13.08%. Owens & Minor’s quarterly revenue was down 2.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.54 EPS. On average, analysts forecast that Owens & Minor Inc. will post $2.03 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 30th. Shareholders of record on Thursday, December 15th will be issued a $0.225 dividend. The ex-dividend date is Tuesday, December 13th. This represents a $0.90 dividend on an annualized basis and a yield of 2.62%. Owens & Minor’s payout ratio is 55.74%.
A number of analysts recently issued reports on OMI shares. Zacks Investment Research upgraded Owens & Minor from a “sell” rating to a “hold” rating in a report on Tuesday, August 9th. Bank of America Corp. started coverage on Owens & Minor in a report on Monday, September 12th. They issued a “neutral” rating for the company. Three equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. The company presently has an average rating of “Hold” and an average price target of $35.60.
A number of hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in shares of Owens & Minor by 8.9% in the second quarter. Vanguard Group Inc. now owns 6,606,293 shares of the company’s stock worth $246,943,000 after buying an additional 540,012 shares in the last quarter. Pzena Investment Management LLC increased its stake in shares of Owens & Minor by 109.6% in the third quarter. Pzena Investment Management LLC now owns 942,143 shares of the company’s stock worth $32,721,000 after buying an additional 492,700 shares in the last quarter. Mackenzie Financial Corp purchased a new stake in shares of Owens & Minor during the second quarter worth about $17,798,000. CWM LLC purchased a new stake in shares of Owens & Minor during the second quarter worth about $16,578,000. Finally, Emerald Acquisition Ltd. purchased a new stake in shares of Owens & Minor during the second quarter worth about $15,173,000. Institutional investors own 93.85% of the company’s stock.
About Owens & Minor
Owens & Minor, Inc is a global healthcare services company. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices in the United States and Europe. The Company operates in two segments: Domestic and International.
Receive News & Stock Ratings for Owens & Minor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor Inc. and related stocks with our FREE daily email newsletter.